Back to Search
Start Over
The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
- Source :
-
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2007 May; Vol. 375 (3), pp. 205-20. Date of Electronic Publication: 2007 Mar 06. - Publication Year :
- 2007
-
Abstract
- This study characterized the pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, its metabolite, ADL 08-0011, and methylnaltrexone. The activities of the compounds were investigated with respect to human or guinea pig opioid receptor binding and function in recombinant cell lines and mechanical responsiveness of the guinea pig ileum. Alvimopan and ADL 08-0011 had higher binding affinity than methylnaltrexone at human mu opioid receptors (pK (i) values of 9.6, 9.6, and 8.0, respectively). The compounds had different selectivities for the mu receptor over human delta and guinea pig kappa opioid receptors. ADL 08-0011 had the highest mu receptor selectivity. With respect to their mu opioid receptor functional activity ([(35)S]GTPgammaS incorporation), methylnaltrexone had a positive intrinsic activity, consistent with partial agonism, unlike alvimopan and ADL 08-0011, which had negative intrinsic activities. Alvimopan, ADL 08-0011, and methylnaltrexone antagonized inhibitory responses mediated by the mu opioid agonist, endomorphin-1 (pA (2) values of 9.6, 9.4, and 7.6, respectively) and by U69593, a kappa opioid agonist (pA (2) values of 8.4, 7.2, and 6.7, respectively). In morphine-naive guinea pig ileum, methylnaltrexone reduced, while alvimopan and ADL 08-0011 increased, the amplitude of electrically evoked contractions and spontaneous mechanical activity. In tissue from morphine-dependent animals, alvimopan and ADL 08-0011 increased spontaneous activity to a greater degree than methylnaltrexone. The data suggested that alvimopan-induced contractions resulted predominantly from an interaction with kappa opioid receptors. It is concluded that alvimopan, ADL 08-0011, and methylnaltrexone differ in their in vitro pharmacological properties, particularly with respect to opioid receptor subtype selectivity and intrinsic activity. The clinical significance of the data from this study remains to be determined.
- Subjects :
- Analgesics, Opioid metabolism
Analgesics, Opioid pharmacology
Animals
Benzeneacetamides pharmacology
CHO Cells
Cricetinae
Cricetulus
Dose-Response Relationship, Drug
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- metabolism
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- pharmacology
Guanosine 5'-O-(3-Thiotriphosphate) metabolism
Guinea Pigs
Humans
Ileum drug effects
Ileum metabolism
Ileum physiology
In Vitro Techniques
Male
Morphine pharmacology
Muscle Contraction drug effects
Naltrexone metabolism
Naltrexone pharmacology
Oligopeptides metabolism
Oligopeptides pharmacology
Piperidines metabolism
Pyrrolidines pharmacology
Quaternary Ammonium Compounds metabolism
Quaternary Ammonium Compounds pharmacology
Receptors, Opioid agonists
Receptors, Opioid genetics
Receptors, Opioid, delta agonists
Receptors, Opioid, delta antagonists & inhibitors
Receptors, Opioid, delta genetics
Receptors, Opioid, kappa agonists
Receptors, Opioid, kappa antagonists & inhibitors
Receptors, Opioid, kappa genetics
Receptors, Opioid, mu agonists
Receptors, Opioid, mu antagonists & inhibitors
Receptors, Opioid, mu genetics
Recombinant Proteins
Transfection
Naltrexone analogs & derivatives
Narcotic Antagonists metabolism
Narcotic Antagonists pharmacology
Piperidines pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0028-1298
- Volume :
- 375
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Naunyn-Schmiedeberg's archives of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 17340127
- Full Text :
- https://doi.org/10.1007/s00210-007-0146-x